{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T01:00:35Z","timestamp":1771981235572,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hypo-attenuated leaflet thickening (HALT) in bioprosthetic aortic valve has been studied, but its equivalent in bioprosthetic mitral valve (bMV) remains uncharacterized. We sought to identify the prevalence, hemodynamic characteristics, and significance of anticoagulation therapy in bMV HALT.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A single-center cross-sectional study of 53 consecutive patients who underwent mitral valve replacement (MVR) with bMV between 2007 and 2017 was conducted. Cardiac-gated contrasted CT scans were obtained. Anticoagulant and antiplatelet therapy use were ascertained at the time of hospital discharge and CT scanning. Patient characteristics, postoperative stroke, and hemodynamic profile by echocardiogram were obtained to descriptively characterize the prevalence and characteristics associated with bMV HALT.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Three patients (5.7%) were found to have a HALT on bMV. The mean time from index MVR to CT scan was 3.4\u2009\u00b1\u20090.8\u2009years in HALT cohort and 3.4\u2009\u00b1\u20092.7\u2009years in non-HALT cohort. Fifty patients (94.3%) were discharged on warfarin, and 37 patients (69.8%) were on warfarin at the time of CT scans. One patient with HALT was on therapeutic warfarin at the time of the CT scan that identified HALT. All three patients were asymptomatic at the time of CT scan. In patients with HALT, mean transmitral pressure gradient were 8, 5, and 2.7\u2009mmHg, all with trivial or mild mitral regurgitation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In this study, the prevalence of HALT was low at 5.7%, all presenting without symptoms. One patient presented with HALT while on therapeutic oral anticoagulation, which may suggest thrombotic etiology may not adequately explain HALT.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13019-020-01120-3","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T21:02:24Z","timestamp":1588885344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypo-attenuated leaflet thickening in surgically-implanted mitral bioprosthesis"],"prefix":"10.1186","volume":"15","author":[{"given":"Soh","family":"Hosoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2367-8354","authenticated-orcid":false,"given":"Makoto","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,7]]},"reference":[{"key":"1120_CR1","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","volume":"373","author":"RR Makkar","year":"2015","unstructured":"Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, De Backer O, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015\u201324.","journal-title":"N Engl J Med"},{"key":"1120_CR2","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","volume":"389","author":"T Chakravarty","year":"2017","unstructured":"Chakravarty T, S\u00f8ndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389:2383\u201392.","journal-title":"Lancet."},{"key":"1120_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jcmg.2017.02.005","volume":"10","author":"H Jilaihawi","year":"2017","unstructured":"Jilaihawi H, Asch FM, Manasse E, Ruiz CE, Jelnin V, Kashif M, et al. Systematic CT methodology for the evaluation of subclinical leaflet thrombosis. JACC Cardiovasc Imaging. 2017;10:461\u201370.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1120_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.chest.2016.04.015","volume":"150","author":"TA Schwann","year":"2016","unstructured":"Schwann TA, Habib RH, Suri RM, Brennan JM, He X, Thourani VH, et al. Variation in warfarin use at hospital discharge after isolated bioprosthetic mitral valve replacement: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. Chest. 2016;150:597\u2013605.","journal-title":"Chest."},{"key":"1120_CR5","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jtcvs.2014.05.014","volume":"148","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg. 2014;148:e1\u2013132.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1120_CR6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jacc.2017.07.715","volume":"70","author":"T Rodriguez-Gabella","year":"2017","unstructured":"Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodes-Cabau J. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and Management of Surgical and Transcatheter Valve Degeneration. J Am Coll Cardiol. 2017;70:1013\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"1120_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001596","volume":"8","author":"T Leetmaa","year":"2015","unstructured":"Leetmaa T, Hansson NC, Leipsic J, Jensen K, Poulsen SH, Andersen HR, et al. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv. 2015;8:e001596.","journal-title":"Circ Cardiovasc Interv"},{"key":"1120_CR8","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.jacc.2016.08.010","volume":"68","author":"NC Hansson","year":"2016","unstructured":"Hansson NC, Grove EL, Andersen HR, Leipsic J, Mathiassen ON, Jensen JM, et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol. 2016;68:2059\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"1120_CR9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/eurheartj\/ehv526","volume":"37","author":"G Pache","year":"2016","unstructured":"Pache G, Schoechlin S, Blanke P, Dorfs S, Jander N, Arepalli CD, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J. 2016;37:2263\u201371.","journal-title":"Eur Heart J"},{"key":"1120_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.117.030729","volume":"137","author":"D Dvir","year":"2018","unstructured":"Dvir D, Bourguignon T, Otto CM, Hahn RT, Rosenhek R, Webb JG, et al. Standardized definition of structural valve degeneration for surgical and Transcatheter bioprosthetic aortic valves. Circulation. 2018;137:388\u201399.","journal-title":"Circulation."},{"key":"1120_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.jcin.2017.01.045","volume":"10","author":"J Jose","year":"2017","unstructured":"Jose J, Sulimov DS, El-Mawardy M, Sato T, Allali A, Holy EW, et al. Clinical bioprosthetic heart valve thrombosis after Transcatheter aortic valve replacement: incidence, characteristics, and treatment outcomes. JACC Cardiovasc Interv. 2017;10:686\u201397.","journal-title":"JACC Cardiovasc Interv"},{"key":"1120_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ejcts\/ezy033","volume":"54","author":"D Richardt","year":"2018","unstructured":"Richardt D, Haban-Rackebrandt SL, Stock S, Scharfschwerdt M, Sievers HH. A matter of thrombosis: different thrombus-like formations in balloon-expandable transcatheter aortic valve prostheses. Eur J Cardiothorac Surg. 2018;54:157\u201361.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1120_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/ejcts\/ezx512","volume":"54","author":"O Zibdeh","year":"2018","unstructured":"Zibdeh O, Bugg I, Patel S, Twine G, Unsworth-White J. Randomized trial of the Carpentier-Edwards supra-annular prosthesis versus the Medtronic mosaic aortic prosthesis: 10-year results. Eur J Cardiothorac Surg. 2018;54:281\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1120_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jcin.2015.03.005","volume":"8","author":"E De Marchena","year":"2015","unstructured":"De Marchena E, Mesa J, Pomenti S, Marin Y, Kall C, Marincic X, et al. Thrombus formation following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2015;8:728\u201339.","journal-title":"JACC Cardiovasc Interv"},{"key":"1120_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcmg.2016.11.005","volume":"10","author":"R Yanagisawa","year":"2017","unstructured":"Yanagisawa R, Hayashida K, Yamada Y, Tanaka M, Yashima F, Inohara T, et al. Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. JACC Cardiovasc Imaging. 2017;10:12\u20134.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1120_CR16","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the Management of Patients with Valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70:252\u201389.","journal-title":"J Am Coll Cardiol"},{"key":"1120_CR17","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","volume":"10","author":"RA Nishimura","year":"2014","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA\/ACC guideline for the Management of Patients with Valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;10:2438\u201388.","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01120-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-020-01120-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01120-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T23:33:32Z","timestamp":1620344012000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-020-01120-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1120"],"URL":"https:\/\/doi.org\/10.1186\/s13019-020-01120-3","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,7]]},"assertion":[{"value":"18 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Toyohashi Heart Center Institutional Review Board and individual consent was waived (THC-00048356).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the final version of the manuscript and consented for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}